Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:1329-1330 (30 June), doi:10.1136/bmj.39245.570093.BE
Targeting high risk groups should remain the priority
| The first 150 words of the full text of this article appear below. |
In this week's BMJ, two analysis articles about testing for HIV argue for changes in policy that would expand the number of people routinely tested by promoting opt-out approaches.1 2 Both papers argue that this would increase the proportion of the population who know their serostatus and would decrease the number of late diagnoses of HIV. The papers agree about the benefits of swift diagnosis of HIV, including reduced mortality and morbidity, less onward transmission because treatment should reduce infectiousness, and reduced costs of acute treatment and lost productivity.
We argue that a more precise goal for any changes in policy should be to reduce the average time between HIV infection and diagnosis in people who become infected.3 This goal allows a range of measures of success beyond a CD4 count below 200x106/l and acknowledges that the earlier HIV is diagnosed the better.
As the secretary general
Catherine Dodds, research fellow, Peter Weatherburn, director
Sigma Research, University of Portsmouth, London SW8 1XJ
catherine.dodds@sigmaresearch.org.uk
Read all Rapid Responses